Ajay Piramal

Piramal Pharma Solutions Invests ~CAD$25 Million to Expand its Aurora, Canada Facility With a State-of-the-art API Manufacturing Wing

Retrieved on: 
Mardi, janvier 28, 2020
Contract manufacturing organization, Pharmaceutical industry, Piramal, Pharma, Rajasthani people, Piramal Group, Ajay Piramal

It will also include filtration and drying capabilities that will enhance service offerings at Piramal Pharma Solutions' Aurora facility.

Key Points: 
  • It will also include filtration and drying capabilities that will enhance service offerings at Piramal Pharma Solutions' Aurora facility.
  • Peter DeYoung, CEO, Piramal Pharma Solutions said, "We are delighted to announce the capacity expansion at our Aurora facility in Canada.
  • As a Patient Centric organization, Piramal Pharma Solutions is committed to serving the patient community and reducing the burden of disease."
  • Piramal Pharma Solutions is a contract development and manufacturing organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life cycle.

Piramal Pharma Solutions Invests ~CAD$25 Million to Expand its Aurora, Canada Facility With a State-of-the-art API Manufacturing Wing

Retrieved on: 
Mardi, janvier 28, 2020
Contract manufacturing organization, Pharmaceutical industry, Piramal, Pharma, Rajasthani people, Piramal Group, Ajay Piramal

It will also include filtration and drying capabilities that will enhance service offerings at Piramal Pharma Solutions' Aurora facility.

Key Points: 
  • It will also include filtration and drying capabilities that will enhance service offerings at Piramal Pharma Solutions' Aurora facility.
  • Peter DeYoung, CEO, Piramal Pharma Solutions said, "We are delighted to announce the capacity expansion at our Aurora facility in Canada.
  • As a Patient Centric organization, Piramal Pharma Solutions is committed to serving the patient community and reducing the burden of disease."
  • Piramal Pharma Solutions is a contract development and manufacturing organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life cycle.

Piramal Pharma Solutions recognized by Frost & Sullivan for its End-to-End Integrated Services Across the Entire Drug Development Life Cycle

Retrieved on: 
Mardi, juin 18, 2019
Contract manufacturing organization, Pharmaceutical industry, Pharma, Economy of India, Companies, Rajasthani people, States and union territories of India, Piramal Group, Ajay Piramal

Through its 12 development centersand manufacturing sites across North America, Europe, and Asia, PPS provides end-to-end capabilities to its pharmaceutical customers across the entire drug development life cycle.

Key Points: 
  • Through its 12 development centersand manufacturing sites across North America, Europe, and Asia, PPS provides end-to-end capabilities to its pharmaceutical customers across the entire drug development life cycle.
  • "PPS' offerings include drug discovery, drug development, and drug substance and product commercial manufacturing.
  • Vivek Sharma, CEO, Piramal Pharma Solutions said, "We are delighted to receive this award from Frost & Sullivan, one of the industry'smost credible companies, for quality recognition.
  • Piramal Pharma Solutions is a contract development and manufacturing organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life cycle.

Piramal Pharma Solutions recognized by Frost & Sullivan for its End-to-End Integrated Services Across the Entire Drug Development Life Cycle

Retrieved on: 
Mardi, juin 18, 2019
Contract manufacturing organization, Pharmaceutical industry, Pharma, Economy of India, Companies, Rajasthani people, States and union territories of India, Piramal Group, Ajay Piramal

Through its 12 development centersand manufacturing sites across North America, Europe, and Asia, PPS provides end-to-end capabilities to its pharmaceutical customers across the entire drug development life cycle.

Key Points: 
  • Through its 12 development centersand manufacturing sites across North America, Europe, and Asia, PPS provides end-to-end capabilities to its pharmaceutical customers across the entire drug development life cycle.
  • "PPS' offerings include drug discovery, drug development, and drug substance and product commercial manufacturing.
  • Vivek Sharma, CEO, Piramal Pharma Solutions said, "We are delighted to receive this award from Frost & Sullivan, one of the industry'smost credible companies, for quality recognition.
  • Piramal Pharma Solutions is a contract development and manufacturing organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life cycle.

Piramal Pharma Solutions Recognized as ‘Industry Partner of the Year’ at the Global Generics & Biosimilars Awards 2018

Retrieved on: 
Mercredi, octobre 17, 2018
Health, Economy of India, CNX Nifty, Biosimilar, Biotechnology, Drugs, Pharma, India, Piramal Group, Ajay Piramal

Piramal Pharma Solutions (PPS) has been recognized as the 'Industry Partner of the Year' at the prestigious Global Generics & Biosimilars Awards 2018, held recently in Madrid, Spain.

Key Points: 
  • Piramal Pharma Solutions (PPS) has been recognized as the 'Industry Partner of the Year' at the prestigious Global Generics & Biosimilars Awards 2018, held recently in Madrid, Spain.
  • Vivek Sharma, Chief Executive Officer, Piramal Pharma Solutions said, "We are honored to receive this award, and I congratulate the Piramal Pharma Solutions team that made this victory possible through its collective efforts and dedication.
  • The Global Generics & Biosimilars Awards are amongst the most coveted recognitions in the pharmaceutical industry, that recognize the efforts made by global generics and biosimilars sectors, to make affordable medicines available to more patients across the globe.
  • Piramal Pharma Solutions is a global leader in pharmaceutical manufacturing, with a large portfolio of Active Pharmaceutical Ingredients (APIs), intermediates and formulations.